Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of peptidomimetics and other bioactive molecules. Its structure features both a protected amine (BOC group) and a carboxylic acid functionality, making it ideal for use in solid-phase and solution-phase peptide coupling reactions. Commonly employed in medicinal chemistry for building constrained cyclic scaffolds that enhance metabolic stability and receptor selectivity. Also utilized in the preparation of enzyme inhibitors and drug candidates targeting central nervous system disorders due to the favorable pharmacokinetic properties imparted by the cyclohexane ring.